BRIDGEBIO ONCOLOGY THERAPEUT
BBOTNASDAQ🏆 #3509 by market capEarnings Nov 18US Equity
$2.79▲ $0.10 (+3.91%)
🌅 Pre-market$2.71▼ 2.87%Regular close · extended-hours price shownTrack BBOT
Get earnings, price moves & breaking news on Telegram
24h▲ 3.9%
7d▼ 1.4%
14d▼ 5.3%
30d▼ 28.8%
ytd▼ 77.6%
1y▼ 75.9%
🏦Market Cap
$224M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
—
Insufficient data
BRIDGEBIO ONCOLOGY THERAPEUT
BBOTAnalyst Ratings
Price
$2.79
Total
9
Raised
0
Lowered
0
Avg PT
$19.00
H / L
$22 / $15
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Morgan Stanley | Reiterated | Overweight | 2026-10-21 | $18.00 | +545.20% |
Oppenheimer | Reiterated | Outperform | 2026-10-20 | $23.00 | +724.40% |
JP Morgan | Reiterated | Overweight | 2026-09-11 | — | — |
Leerink Partners | Reiterated | Outperform | 2026-09-10 | $25.00 | +796.10% |
Canaccord Genuity | Reiterated | Buy | 2026-09-09 | $20.00 | +616.80% |
Raymond James | Reiterated | Outperform | 2026-09-09 | $22.00 | +688.50% |
Stifel | Reiterated | Buy | 2026-09-09 | — | — |
Wedbush | Reiterated | Outperform | 2026-09-09 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2026-03-06 | — | — |
Institution
Morgan Stanley
Reiterated · Overweight · 2026-10-21
$18.00
+545.20%
Oppenheimer
Reiterated · Outperform · 2026-10-20
$23.00
+724.40%
JP Morgan
Reiterated · Overweight · 2026-09-11
—
—
Leerink Partners
Reiterated · Outperform · 2026-09-10
$25.00
+796.10%
Canaccord Genuity
Reiterated · Buy · 2026-09-09
$20.00
+616.80%
Raymond James
Reiterated · Outperform · 2026-09-09
$22.00
+688.50%
Stifel
Reiterated · Buy · 2026-09-09
—
—
Wedbush
Reiterated · Outperform · 2026-09-09
—
—
HC Wainwright & Co.
Reiterated · Buy · 2026-03-06
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space